Clinical Trials List
2019-06-01 - 2025-12-31
Phase I
Recruiting3
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- Yu-Chieh Tsai Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 楊景堯 Division of General Internal Medicine
- 徐偉勛 Division of General Internal Medicine
- 林育麟 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- YEN-TING LIN
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG 無
- Gee-chen Chang Division of Thoracic Medicine
- JENG-SEN TSENG 無
- TSUNG -YING YANG Division of Thoracic Medicine
- 徐國軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wu-Chou Su Division of General Internal Medicine
- Wei-Pang Chung 無
- Shang-Yin Wu 無
- Po-Lan Su 無
- Jui-Hung Tsai 無
- Yu-Min Yeh 無
- Chien-Chung Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
327 participants
